5 mg Retardtabletten clinical trials

A Phase 3, Multi-center, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

This study is testing a new medicine, Aficamten, for people with a heart condition called obstructive hypertrophic cardiomyopathy. It compares Aficamten to a common medicine, Metoprolol, to see if it helps patients feel better and improve how well their heart works. Researchers want to know if it's safe and effective.